We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Priding themselves with their Aussie-Japanese sushi handrolls, Inigo have introduced the delicacy to London and are now ready to expand. The company has partnered with a leading smokehouse, H. Forman & Son's who provide the kitchen, produce and expertise. Inigo currently have operate from a kiosk in the city centre, with more planned. They offer B2B services and supply corporate businesses including Visa HQ, Amazon HQ and UBS.
days to go: Expired investment: £179,840
Winebuyers connect vineyards and wine merchants directly to the end consumer revolutionising a traditional industry.  They make their revenue by charging the suppliers a monthly fee and have had 2,700 companies registering their interest to be involved in the platform.  The funding will go towards strengthening their infrastructure, extending their marketing activities and to growing the business quickly and efficiently. (SEIS Partial)
days to go: Expired investment: £568,870
The GP Service is a web and application-based platform that provides private consultations for patients across the UK. The aim is to provide a safe and easy journey for individuals who are looking for private medical treatment at their convenience and at an affordable cost. They have established a connection with over 1600 pharmacies across the UK. They have an excellent 5-star trust pilot rating and also are 1st Private Online Provider which has access to NHS Medical Records. With the proceeds, the company will scale the enterprise offering, increase brand awareness and also launch additional revenue opportunities.

Pitch Rated

77%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £907,540
With support from the founders of Bulldog Skincare, Zoopla and Love Film, VITL's aim is to improve the nation's health by offering vitamin packs that are fully personalised to the customer. VITL uses artificial intelligence to decipher which nutrients a person needs to ensure a healthy lifestyle. Effectively cutting out the cost of a private nutritionist.

Pitch Rated

44%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £908,950
Oppo Ice Cream have created one of the world's healthiest dairy ice cream which has fewer calories and less sugar than an apple. This means you can indulge in luxury ice cream without looking like you have.
days to go: Expired investment: £468,420
L'orchidee is a boutique patisserie concept that specialises in macaroons and cakes for all occasions. L'orchidee currently have 3 stores with their most successful store recently opening in Canary Wharf. 
days to go: Expired investment: £33,480
An indoor climbing brand opening in Ellesmere Port, south of Liverpool; Boulder Hut is expected to be the first dedicated bouldering centre in the area. Bouldering is a shorter, sharper version of rock climbing, done without ropes, and is set to be included in the 2020 Olympics.
days to go: Expired investment: £386,200
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph